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Abstract
The blockage of the hERG K+ channels is closely associated with lethal cardiac arrhythmia. The 
notorious ligand promiscuity of this channel earmarked hERG as one of the most important 
antitargets to be considered in early stages of drug development process. Herein we report on the 
development of an innovative and freely accessible web server for early identification of putative 
hERG blockers and non-blockers in chemical libraries. We have collected the largest publicly 
available curated hERG dataset of 5,984 compounds. We succeed in developing robust and 
externally predictive binary (CCR ≈0.8) and multiclass models (accuracy ≈0.7). These models are 
available as a web-service freely available for public at http://labmol.farma-cia.ufg.br/predherg/. 
Three following outcomes are available for the users: prediction by binary model, prediction by 
multi-class model, and the probability maps of atomic contribution. The Pred-hERG will be 
continuously updated and upgraded as new information became available.
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1 Introduction
Several non-cardiovascular drugs (e.g., terfenadine,[1] cisapride,[2] sertindole[3]) have been 
withdrawn from the market due to their ability to inhibit the human ether-à-go-go related 
gene (hERG) K+ channels, which may lead to severe side effects such as heart arrhythmia 
and potentially death.[4] Moreover, the notorious ligand promiscuity of this channel[5] 
earmarked hERG as one of the most important antitargets to be considered in early stages of 
drug development process. Testing a new bioactive molecule for hERG safety is mandatory 
and required by the US FDA. Experimental evaluation of binding affinity to hERG K+ 
channel such as the “gold standard” patch-clamp electrophysiology,[6,7] the in vivo test on 
zebrafish,[8] etc., are laborious, expensive, and time consuming.[9] Therefore, there is a need 
in developing computational tools to reliably identify and filter out potential hERG blockers. 
Recently, we have built a series of QSAR (Quantitative Structure-Activity Relationship) 
models for hERG liability[10] using 4,833 diverse compounds. Herein, these models were 
retrained using a considerably larger dataset of 5,984 compounds and an improved 
validation protocol. Our Pred-hERG web-server (Figure 1) incorporates the new models and 
allows users for fast screening, even on large libraries of compounds. This service is freely 
available for public at http://labmol.farmacia.ufg.br/predherg/.
2 Pred-hERG Characteristics
2.1 Dataset Retrieval and Curation
We collected all available records related to the hERG channel from the ChEMBL[11] v.19 
database (July, 2014). The original dataset consisted of 14,397 chemical records. Dataset 
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curation (addition of explicit hydrogens, aromatization of functional groups, 2D structure 
cleaning, fragments removal, etc.) was performed using Indigo Open Source Standardizer 
following the workflow described by Fourches et al.[12] including the duplicate analysis. In 
addition, our previous experience showed higher chance of erroneous annotation for very 
active compounds (e.g., μM were confused with nM) and thus we flagged the compounds 
with activities lower than 0.3 μM. We also added to the flagged list compounds with activity 
higher than 300 μM. The flagged compounds comprehended around 10 % of the dataset and 
their chemical structures and activity values were validated manually by analyzing the 
original papers. Duplicates with confirmed conflicting annotations were removed. In the 
case of identical activities, only one record was kept. In total, 1311 compounds were 
annotated correctly, 140 were mis-annotated and corrected. One compound was absent in 
corresponding reference. Several compounds that had “less/greater than” operators were 
removed because they did not obey the threshold limit. Curated dataset consisted of 5,984 
compounds including 2,191 non-blockers (activity ≥10 μM), 2,565 weak/moderate blockers 
(1 μM ≤activity ≤ 10 μM), and 1,228 strong blockers (≤1 μM). The dataset is available at 
http://labmol.farmacia.ufg.br/predhergmorein-formation/.
2.2 QSAR Modeling
Binary and multi-class QSAR models have been developed and validated according to the 
OECD principles, using two types of molecular descriptors and support vector machines 
(SVM)[13] modeling technique. Morgan fingerprints and Chemistry Development Kit 
(CDK)[14] descriptors were calculated using RDKit (http://www.rdkit.org) and PaDEL-
Descriptor plugin for KNIME.[15] The models were built using the qsaR v.1.5 package 
(http://qsarr.r-forge.r-project.org/) and its integration workflow for KNIME v. 2.10.3. All 
these procedures were united in KSAR workflow. The 5-fold external cross-validation 
procedure was used to estimate the robustness of the developed models. Since there is no 
difference between random and rational selection of external folds for big datasets,[16] the 
compounds in the external folds were chosen randomly. The predicted probability maps 
revealing the predicted probability of atomic contributions for the structures became 
available in this version of Pred-hERG. The original code of probability maps[17] 
implemented in Python is also freely accessible for users. More detailed description of the 
QSAR modeling process is available in the Supporting Information.
2.3 Model Implementation and Usage
The Pred-hERG server employs many tools including Flask (http://flask.pocoo.org/), 
uWSGI (https://uwsgi-docs.read-thedocs.org/), nginx (http://nginx.org/), Python (https://
www.python.org/), and JavaScript (http://www.ecma-inter-national.org/). Towards more 
user-friendly interface, Pred-hERG provides an interactive web interface, including the 
JSME, a free molecule editor in JavaScript,[18] written on JavaScript and support the latest 
versions of all most popular browsers. Users will not need any Java or Flash plugins to use it 
in their browser. Pred-hERG is implemented on Ubuntu Server.
The new version of the web server (Figure 1) has a simpler intuitive user interface. There are 
three possible ways of entering molecular structure information: (i) directly paste the 
SMILES string of the structure in the appropriate area and hit “Predict” button; (ii) draw the 
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query molecule in the “molecular editor” box, click on the “Get SMILES” button to translate 
it to SMILES, and then hit “Predict” button. After the completion of the job, which takes 
less than one second for one molecule, the user will receive the outcome with the predicted 
probability maps in the page. If the user wants to predict more molecules, click on the 
“Clean” button and draw or paste and predict the next molecule. Alternatively, the user can 
also send a list of molecules by clicking on the “List of Molecules” button. In this case, is 
necessary to fill out the form with name and e-mail. Then, just paste the list of SMILES of 
the molecules in the box or upload a *.smi or *.sdf file with all the molecules, and submit 
the job to the server. The results will be sent by e-mail.
2.4 Outcome Interpretation
The user will receive three outcomes: (i) binary prediction (Consensus AD model); (ii) 
multiclass prediction (Consensus AD model); and (iii) probability maps extracted from the 
binary models using Morgan fingerprints. The results from each prediction are directly 
displayed in the website, along with the probability of the prediction for each class, which 
may influence the final decision of future use for that particular compound. For binary 
models, the probability of the compound to be hERG non-blocker or blocker is reported in 
parenthesis (in this order). Multiclass models have similar outcome, but the user will receive 
the probability of a compound to be a non-blocker, weak/moderate blocker, or strong blocker 
respectively. The predicted probability maps help to visualize the atomic contributions in a 
structure as predicted by the QSAR model. In the map, green atoms or fragments represent 
contribution towards blockage of hERG, while pink means that it contributes to decrease of 
hERG blockage, and gray means no contribution. Gray isolines delimit the region of split 
between the positive (green) and the negative (pink) contribution (see http://lab-
mol.farmacia.ufg.br/predherg/predherghelp/ for an example).
3 Results and Discussion
As illustrated on Figure 2, the combination of different descriptors led to robust and 
predictive QSAR models, with correct classification rate (CCR) ranging between 0.83–0.84 
and a coverage of 0.63–1.0 for binary models and accuracy ranging between 0.66–0.79 and a 
coverage of 0.58–0.81 for multiclass models. Consensus models were built by averaging the 
predicted values from each individual model as follows: Consensus is the average of Morgan 
and CDK models; Consensus AD is the average of the predictions made by Morgan and 
CDK models, but considering the applicability domain (AD); Consensus Rigor is the 
average of Morgan and CDK models, but only when both predictions were inside the AD. 
Divergent predictions between individual models were considered as inconclusive and were 
discarded. The Consensus model yielded the best performance (CCR =0.84 and accuracy 
=0.74 for binary and consensus classifiers, respectively); therefore, it has been selected to be 
the default model to be used in Pred-hERG. The complete statistical results of the developed 
models are available in the Supporting Information (Table S1 and S2).
4 Conclusions
The Pred-hERG web server allows users to identify putative hERG blockers and non-
blockers through a fast and user-friendly interface. No computational or programming skills 
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are required from the user. Prediction time for a compound is less than one second. Three 
following outcomes are available for the users: prediction by binary model, prediction by 
multi-class model, and the probability maps of atomic contribution. The Pred-hERG will be 
continuously updated and upgraded as new information became available. This service is 
freely available for public at http://lab-mol.farmacia.ufg.br/predherg/.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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General scheme for usage of Pred-hERG.
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Evaluation of (a) binary QSAR models and (b) multiclass QSAR models for hERG liability 
implemented in Pred-hERG.
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